ArticleScientific reports2016

Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.

Ibon Garitaonandia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.